163 related articles for article (PubMed ID: 34028973)
1. MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB-EGF/EGFR pathway.
Wang L; Gao Y; Tong D; Wang X; Guo C; Guo B; Yang Y; Zhao L; Zhang J; Yang J; Qin Y; Liu L; Huang C
Mol Oncol; 2021 Nov; 15(11):3147-3163. PubMed ID: 34028973
[TBL] [Abstract][Full Text] [Related]
2. TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB-EGF Expression and Proteolytic Cleavage.
Dong ZR; Sun D; Yang YF; Zhou W; Wu R; Wang XW; Shi K; Yan YC; Yan LJ; Yao CY; Chen ZQ; Zhi XT; Li T
Hepatology; 2020 Sep; 72(3):923-939. PubMed ID: 31867749
[TBL] [Abstract][Full Text] [Related]
3. HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells.
Wang L; Tong D; Guo Q; Wang X; Wu F; Li Q; Yang J; Zhao L; Qin Y; Liu Y; Huang C
Sci Rep; 2018 Feb; 8(1):2431. PubMed ID: 29402992
[TBL] [Abstract][Full Text] [Related]
4. Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells.
Wu X; Zhao B; Cheng Y; Yang Y; Huang C; Meng X; Wu B; Zhang L; Lv X; Li J
Toxicol Appl Pharmacol; 2015 Oct; 288(1):74-83. PubMed ID: 26189965
[TBL] [Abstract][Full Text] [Related]
5. HOXD3 was negatively regulated by YY1 recruiting HDAC1 to suppress progression of hepatocellular carcinoma cells via ITGA2 pathway.
Wang L; Gao Y; Zhao X; Guo C; Wang X; Yang Y; Han C; Zhao L; Qin Y; Liu L; Huang C; Wang W
Cell Prolif; 2020 Aug; 53(8):e12835. PubMed ID: 32557953
[TBL] [Abstract][Full Text] [Related]
6. T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
Ji X; Chen X; Zhang B; Xie M; Zhang T; Luo X; Liu D; Feng Y; Wang Y; Sun M; Li C; Huang W; Xia L
Oncogene; 2022 Apr; 41(15):2225-2238. PubMed ID: 35217793
[TBL] [Abstract][Full Text] [Related]
7. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway.
Zhang JJ; Cao CX; Wan LL; Zhang W; Liu ZJ; Wang JL; Guo Q; Tang H
World J Gastroenterol; 2022 May; 28(17):1781-1797. PubMed ID: 35633908
[TBL] [Abstract][Full Text] [Related]
8. Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma.
Inui Y; Higashiyama S; Kawata S; Tamura S; Miyagawa J; Taniguchi N; Matsuzawa Y
Gastroenterology; 1994 Dec; 107(6):1799-804. PubMed ID: 7958694
[TBL] [Abstract][Full Text] [Related]
9. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
[TBL] [Abstract][Full Text] [Related]
10. Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.
Guo Y; Peng Y; Gao D; Zhang M; Yang W; Linghu E; Herman JG; Fuks F; Dong G; Guo M
Clin Epigenetics; 2017; 9():116. PubMed ID: 29075359
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
12. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells.
Wang F; Sloss C; Zhang X; Lee SW; Cusack JC
Cancer Res; 2007 Sep; 67(18):8486-93. PubMed ID: 17875687
[TBL] [Abstract][Full Text] [Related]
13. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
14.
Gunawardhana N; Jang S; Choi YH; Hong YA; Jeon YE; Kim A; Su H; Kim JH; Yoo YJ; Merrell DS; Kim J; Cha JH
Front Cell Infect Microbiol; 2017; 7():541. PubMed ID: 29379775
[No Abstract] [Full Text] [Related]
15. The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.
Huang P; Xu X; Wang L; Zhu B; Wang X; Xia J
J Cell Mol Med; 2014 Feb; 18(2):218-30. PubMed ID: 24268047
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg3 Decreases NHE1 Expression via Inhibiting EGF-EGFR-ERK1/2-HIF-1
Li X; Tsauo J; Geng C; Zhao H; Lei X; Li X
Am J Chin Med; 2018; 46(8):1915-1931. PubMed ID: 30525897
[TBL] [Abstract][Full Text] [Related]
17. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
18. EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.
Wang L; Sun H; Wang X; Hou N; Zhao L; Tong D; He K; Yang Y; Song T; Yang J; Huang C
Oncotarget; 2016 Jul; 7(29):45302-45316. PubMed ID: 27244890
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
Yagi H; Yotsumoto F; Miyamoto S
Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
[TBL] [Abstract][Full Text] [Related]
20. Activation of Epidermal Growth Factor Receptor in Macrophages Mediates Feedback Inhibition of M2 Polarization and Gastrointestinal Tumor Cell Growth.
Zhao G; Liu L; Peek RM; Hao X; Polk DB; Li H; Yan F
J Biol Chem; 2016 Sep; 291(39):20462-72. PubMed ID: 27507810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
